Common Contracts
3 similar License Agreement contracts by ASLAN Pharmaceuticals LTD
EX-10.4 6 d496922dex104.htm EX-10.4 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2. CONFIDENTIAL – EXECUTION VERSION LICENSE AGREEMENTLicense Agreement • May 5th, 2020 • England and Wales
This License Agreement (this “Agreement”), entered into as of January 3rd, 2018 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having offices at 3200 Walnut Street, Boulder, Colorado 80301, and ASLAN Pharmaceuticals Pte. Ltd., a Singapore corporation, with offices at 83 Clemenceau Avenue #12-03 UE Square, Singapore 239920.
LICENSE AGREEMENTLicense Agreement • March 26th, 2018 • ASLAN Pharmaceuticals LTD • Pharmaceutical preparations • England and Wales
This License Agreement (this “Agreement”), entered into as of January 3rd, 2018 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having offices at 3200 Walnut Street, Boulder, Colorado 80301, and ASLAN Pharmaceuticals Pte. Ltd., a Singapore corporation, with offices at 83 Clemenceau Avenue #12-03 UE Square, Singapore 239920.
LICENSE AGREEMENTLicense Agreement • February 27th, 2018 • ASLAN Pharmaceuticals LTD • Pharmaceutical preparations • England and Wales
This License Agreement (this “Agreement”), entered into as of January 3rd, 2018 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having offices at 3200 Walnut Street, Boulder, Colorado 80301, and ASLAN Pharmaceuticals Pte. Ltd., a Singapore corporation, with offices at 83 Clemenceau Avenue #12-03 UE Square, Singapore 239920.
